TrialX
Image

Using Deep Learning Methods to Analyze Automated Breast Ultrasound Images to Establish a Diagnosis Therapy Assessment and Prognosis Prediction Model of Breast Cancer.

Using Deep Learning Methods to Analyze Automated Breast Ultrasound Images to Establish a Diagnosis Therapy Assessment and Prognosis Prediction Model of Breast Cancer.

Recruiting
18 years and older
Female
Phase N/A

Overview

The purpose of this study is using a deep learning method to analyze the automated breast ultrasound (ABUS) imagings, establish and evaluate a diagnosis, therapy assessment and prognosis prediction model of breast cancer. The model would provide important references for further early prevention, early diagnosis and personalized treatment.

Description

  1. Establishing a database By collecting ABUS and comprehensive breast image data, essential information, clinical treatment information, prognosis, and curative effect information, a complete breast image database is constructed.
  2. Marking ABUS image Three doctors use a semi-automatic method to frame the lesions on the image.
  3. Building the model Using the deep learning method to preprocess, analyze and train the marked image, and finally get a model diagnosis, efficacy evaluation and prognosis prediction model of breast cancer.
  4. Evaluating the model 1Self-validation Analyze the sensitivity, AUC of the breast cancer diagnosis model and the false-positive number on each ABUS volume.
  5. Compared the sensitivity, AUC and the false-positive number with a commercial diagnosis model.

3)By analyzing the size and characteristics of the lesions after neoadjuvant chemotherapy, and predicting the OS and DFS time, the therapy assessment and prognosis prediction model were evaluated.

Eligibility

Inclusion Criteria:

  1. Female patients over 18 years old who come to the two centers for physical examination or treatment;
  2. Complete basic information and image data

Exclusion Criteria:

  1. There is no complete ABUS image data;
  2. The image quality of ABUS image is poor;
  3. In multifocal breast cancer, the correlation between the tumor in the image and the postoperative pathological examination is uncertain.

Study details
    Breast Cancer
    Breast Cancer

NCT04270032

The First Affiliated Hospital of the Fourth Military Medical University

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.